Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted T cells

European Journal of Immunology

Volumn 32, Issue 4, 2002, Pages 1099-1108

  Stober, Detlef ^a   Trobonjaca, Zlatko ^a   Reimann, Jörg ^a   Schirmbeck, Reinhold ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cross presentation; Dendritic cell; Hepatitis B surface antigen

Indexed keywords

AMILORIDE; AMMONIUM CHLORIDE; BETA 2 MICROGLOBULIN; CYTOCHALASIN D; EPITOPE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PRIMAQUINE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LIVER; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; SPLEEN;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; FEMALE; H-2 ANTIGENS; HEPATITIS B SURFACE ANTIGENS; INTERFERON TYPE II; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036232611     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200204)32:4<1099::AID-IMMU1099>3.0.CO;2-8     Document Type: Article

References (35)

1. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation
2. Antibody and cytotoxic T cell responses to soluble hepatitis B virus (HBV) S antigen in mice: Implication for the pathogenesis of HBV-induced hepatitis
3. + cytotoxic T lymphocyte responses in vivo
4. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation
5. 'Empty' Ld molecules capture peptides from endocytosed hepatitis B surface antigen particles for major histocompatibility complex class I-restricted presentation
6. Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous β2-microglobulin
7. Comparison between surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): Composition, structure and immunogenicity
8. Polyclonality and multispecificity of the CTL response to a single viral epitope
9. Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen (HBsAg)
10. Processing of exogenous heat-aggregated (denatured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation
11. Dendritic cells and the control of immunity
12. Cross-presentation, dendritic cells, tolerance and immunity
13. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo
14. IL-12/IL-18-dependent IFNγ release by murine dendritic cells
15. Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells
16. Model for the in vivo assembly of nascent Ld class I molecules and for the expression of unfolded Ld molecules at the cell surface
17. The role of β2-microglobulin in peptide binding by class I molecules
18. + T cell-dependent
19. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
20. Roles of proteasomes, transporter for antigen presentation (TAP), and β2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway
21. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: Protein context influences the degree of TAP-independent presentation
22. Recycling MHC class I molecules and endosomal peptide loading
23. +T cells in vivo
24. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells
25. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules
26. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin
27. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments
28. Endocytosis and dissociation of class I MHC molecules labeled with fluorescent β2 microglobulin
29. Intermediates in the assembly and degradation of class I major histocompatibility complex (MHC) molecules probed with free heavy chain-specific monoclonal antibodies
30. Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: Comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface
31. Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains
32. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric β2-microglobulin complexes
33. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha
34. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
35. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFNγ release by liver NKT cells